About
About Tus-Pharmaceutical Group Co., Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-clearing and detoxifying drugs. It also engages in nutrition and health consulting services; Chinese herbal medicine cultivation; medical research and experimental development; cultural and artistic exchange planning; medical consultation; internet sales; technology promotion, consulting, and agency services; outpatient services; and pharmaceutical wholesale and retail activities. The company was formerly known as Tus-Pharmaceutical Group Co., Ltd. and changed its name to Guhan Pharmaceutical Group Co., Ltd. in November 2025. Guhan Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.
Visit company website
5 years, 5 months ago
Tus-Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 3.6% above its 200 day moving average.
From a valuation standpoint, the stock is 29.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.
Tus-Pharmaceutical Group Co., Ltd's total revenue sank by 2.3% to $98M since the same quarter in the previous year.
Its net income has dropped by 86.5% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 1175.9% to $-13M since the same quarter in the previous year.
Based on the above factors, Tus-Pharmaceutical Group Co., Ltd gets an overall score of 2/5.